Karnataka to appeal HC order on Jan Aushadi Kendras closure
Karnataka Health Minister Dinesh Gundu Rao announces state will appeal HC order quashing closure of Jan Aushadi Kendras in govt hospitals. Read the full story.
Category : Search result: semaglutide generic
Court Rejects Ozempic Patent Extension, Boosts Generic Drug Access
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
India-Russia Summit: Key Outcomes & UPSC Insights
India & Russia sign 16 pacts, chart roadmap till 2030. Key takeaways on labour mobility, trade, defence & nuclear energy. Essential analysis for UPSC aspirants on bilateral ties, repo rate, labour codes & more.
Delhi HC sides with Dr Reddy's in semaglutide patent case
Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
India's Drug Patent Wars: Need for Special Courts?
A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.
WHO issues first global guidelines for GLP-1 obesity drugs
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
Dr Reddy's Wins Delhi HC Nod to Export Semaglutide
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
Oral Ozempic 2.0: Game-Changer Weight Loss Pills
Novo Nordisk and Eli Lilly develop daily oral weight loss pills with 10-16% average weight loss in trials. Pending FDA approval, these could replace injections.
Indian Companies Set for Semaglutide Device Windfall
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.
Michelle Obama's Weight Loss Sparks Ozempic Speculation
Michelle Obama faces Ozempic rumors after revealing slimmer frame in Annie Leibovitz photoshoot. Social media erupts with speculation despite no evidence. Read the full story.
OneSource Pharma Raises FY28 Revenue Target to $500M
OneSource Pharma hikes FY28 revenue guidance to over $500 million, plans $100M expansion for weight-loss drugs like semaglutide. CEO reveals accelerated growth strategy.
Biocon Banks on Weight-Loss Drugs, Ups Biosimilar Stake
Biocon's generics business surges 24% driven by weight-loss drugs liraglutide & semaglutide. CEO Siddharth Mittal reveals strategy to capture share of the booming $95 billion GLP-1 market.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
White House Deal Cuts Ozempic & Wegovy Prices in India
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Obesity Drugs: Not Miracle Cures
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
Trump's $149 Weight-Loss Drug Deal with Ozempic Maker
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.
Viral Molecule Weight Loss Pills: Experts Warn Russians
Discover why molecule-based weight loss supplements are going viral among young Russians. Learn about the science, risks, and expert warnings about this concerning health trend.
FDA Approves Oral Weight Loss Drug Rybelsus
Breaking news: US FDA approves Rybelsus, the groundbreaking oral weight loss medication that mimics popular injection drugs. Discover how this pill could revolutionise obesity treatment in India and worldwide.
GLP-1 Drugs: How Ozempic & Mounjaro Work
Discover how GLP-1 receptor agonists are revolutionizing diabetes and obesity treatment. Learn the mechanism behind popular drugs like Ozempic, Mounjaro, and other game-changing medications.
Weight Loss Shots: Bengaluru Doctors Issue Warning
Bengaluru medical experts sound alarm on diabetes drugs being misused for weight loss, highlighting dangerous side effects and long-term health risks.
How GLP-1 Drugs Are Quietly Reshaping America's Waistline
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Semaglutide: Weight Loss Drug Protects Heart
Groundbreaking research shows popular weight-loss drug semaglutide significantly reduces heart disease risk, offering dual benefits for patients struggling with obesity and cardiovascular health.
Semaglutide Boosts Heart Health in New Study
Groundbreaking research from Pune reveals diabetes drug semaglutide significantly reduces cardiovascular risks in non-diabetic patients, offering dual benefits for weight and heart health.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Indian Pharma Wins Crucial Legal Battle for Generic Drugs
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Generic Meds Causing Swollen Feet? Senior Alert!
Neurologist warns about unexpected side effects of common blood pressure and diabetes medications in older adults. Learn the signs and when to consult your doctor.
Indian Pharma Q2 Preview: Steady Growth Amid Challenges
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Supreme Court allows generic SMA drug in blow to Roche
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.
Page 1 of 2